HTBX (HTBX) has the following price history information. Looking back at HTBX historical stock prices for the last five trading days, on April 26, 2022, HTBX opened at $2.48, traded as high as $2.48 and as low as $2.24, and closed at $2.28. Trading volume was a total of 61.60K shares. On April 27, 2022, HTBX opened at $2.35, traded as high as $2.35 and as low as $2.22, and closed at $2.24. Trading volume was a total of 49.70K shares. On April 28, 2022, HTBX opened at $2.26, traded as high as $2.43 and as low as $2.26, and closed at $2.38. Trading volume was a total of 86.00K shares. On April 29, 2022, HTBX opened at $2.38, traded as high as $2.56 and as low as $2.37, and closed at $2.37. Trading volume was a total of 110.00K shares. On May 02, 2022, HTBX opened at $2.41, traded as high as $2.48 and as low as $2.33, and closed at $2.38. Trading volume was a total of 43.60K shares.

HTBX Historical Stock Prices By Date:

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 20142015201620172018201920202021202220232024

Below, we examine the compound annual growth rate — CAGR for short — of an investment into HTBX shares, starting with a $10,000 purchase of HTBX, and working forward through the historical stock price information to today.

Growth of $10,000.00 Without Dividends Reinvested
Start date:	04/25/2014
End date:	05/02/2022
Start price/share:	$396.90
End price/share:	$2.38
Dividends collected/share:	$0.00
Total return:	-99.40%
Average Annual Total Return:	-47.14%
Starting investment:	$10,000.00
Ending investment:	$60.01
Years:	8.02

HTBX Historical Price Range
Date	Open	High	Low	Close	Volume
04/26/2022	$2.48	$2.48	$2.24	$2.28	61.60K
04/27/2022	$2.35	$2.35	$2.22	$2.24	49.70K
04/28/2022	$2.26	$2.43	$2.26	$2.38	86.00K
04/29/2022	$2.38	$2.56	$2.37	$2.37	110.00K
05/02/2022	$2.41	$2.48	$2.33	$2.38	43.60K

About HTBX

NightHawk Biosciences is a biopharmaceutical company focusing on the development and commercialization of therapies that arm the immune system against a range of diseases including cancer and infectious disease. Co.'s gp96 platform and RapidVax® platforms are designed to utilize the ability of gp96 to constitutively transport predefined antigens of interest to antigen presenting cells that in turn stimulate an antigen-specific immune response that includes B cells, CD4+ T-cells, and cytotoxic CD8+ T-cells. HS-110 (viagenpumatucel-L), an allogeneic therapy, is Co.'s main gp96 asset having completed Phase 2 enrollment of a non-small cell lung cancer clinical trial.

HTBX Historical Closing Prices
Date	Close
04/26/2022	$2.28
04/27/2022	$2.24
04/28/2022	$2.38
04/29/2022	$2.37
05/02/2022	$2.38

Healthcare Historical Prices

HTBX is categorized under the Healthcare sector; below are some other companies in the same sector: HTGM Historical Stock Prices HTL Historical Stock Prices HTWR Historical Stock Prices HWAY Historical Stock Prices HYH Historical Stock Prices HZNP Historical Stock Prices IART Historical Stock Prices IAS Historical Stock Prices IBIO Historical Stock Prices ICAD Historical Stock Prices Also explore: HTBX shares outstanding history Free HTBX Email Alerts: Get Dividend Alerts Get SEC Filing Alerts

HTBX Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.